We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan, Sandoz Seek Copaxone Patent Invalidation from Supreme Court
Mylan, Sandoz Seek Copaxone Patent Invalidation from Supreme Court
Mylan and Sandoz have filed a legal brief with the U.S. Supreme Court challenging Teva’s appeal to salvage the patent protection on its blockbuster multiple sclerosis drug Copaxone.